International Journal of Pharmaceutical Compounding

A subscription to IJPC provides on-line access to full-text, full-color, printable PDF copies of all issues and individual articles published by the Journal since 1997.

LEARN MORE

Calcium Acetate 667-mg Capsules

Author(s): Allen Loyd V Jr

Issue: May/Jun 2013 - Volume 17, Number 3
View All Articles in Issue

Page(s): 229

Download in electronic PDF format for $75

Abstract: A formulation for preparing Calcium Acetate 667-mg Capsules. Includes ingredients, method of preparation, discussion, and references for the compounding pharmacist.

Related Keywords: formulation, calcium acetate, capsule formulation, hyperphosphatemia, drug shortages

Related Categories: FORMULATIONS, NUTRITION AND NUTRICEUTICALS, ENDOCRINOLOGY/HORMONES/ MENOPAUSE/ANDROPAUSE

Printer-Friendly Version

Title/Author (Click for Abstract / Details / Purchase)	Issue/Page View/Buy
Related Articles from IJPC
Calcium Acetate 667-mg Capsules Allen Loyd V Jr	May/Jun 2013 Pg. 229
Basics of Compounding for Cough Allen Loyd V Jr	Nov/Dec 2004 Pg. 462-465
Stability Studies of Fludrocortisone Acetate Capsules and Fludrocortisone Acetate Titrated Powders (Powder Triturates) Brandin Thibaut, Wasilewski Maya, Panuccio Camille, Bouguergour Cyrielle, Primas Nicolas, Lamy Edouard, Jean Christophe, Bertault-Peres Pierre, Rathelot Pascal, Curti Christophe, Vanelle Patrice	Mar/Apr 2022 Pg. 150-154
Cortisone Acetate 25-mg Capsules Allen Loyd V Jr	Nov/Dec 2013 Pg. 501
Physical Compatibility of Calcium Acetate and Potassium Phosphates in Parenteral Nutrition Solutions Containing Aminosyn II Zhang Yanping, Xu Quanyun, Trissel Lawrence A, Baker Mary B	Sep/Oct 1999 Pg. 415-420
The Basics of Compounding: Compounding Special Capsules Allen Loyd V Jr	Jul/Aug 1999 Pg. 291-294
Capsule and Tablet Diluents, Featured Excipient: Allen Loyd V Jr	Jul/Aug 2000 Pg. 306-310
Compatibility of Caspofungin Acetate Injection with Other Drugs During Simulated Y-Site Coadministration Chan Pak, Heatherly Kathy, Kupiec Thomas C, Trissel Lawrence A	May/Jun 2008 Pg. 276-278
Pharmaceutical Development of Enteric-Release Hard Gelatin Capsules in the Compounding Setting de Oliveira Ferreira Anderson, Holandino Carla	Mar/Apr 2008 Pg. 163-169
Release of Morphine Sulfate from Compounded Slow-Release Capsules: The Effect of Formulation on Release Bogner Robin H, Szwejkowski Jessica, Houston Alana	Sep/Oct 2001 Pg. 401-405
Formulation and Stability Study of Eslicarbazepine Acetate Oral Suspensions for Extemporaneous Compounding Zhao Fang, Dave Vivek S, Mar Mazin Z, Perri Jonathan R	Sep/Oct 2018 Pg. 433-439
Effects of Calcium Polystyrene Sulfonate Formulation Change from Dry Syrup to Oral Solution in Patients with Chronic Kidney Disease Kobayashi Shunsuke, Ogawara Yuka, Imamura Yoshihiko, Kitaoka Akira, Yasu Takeo	Sep/Oct 2022 Pg. 436-439
Eslicarbazepine Acetate 40-mg/mL in Ora-Plus with Ora-Sweet or Ora-Sweet SF Suspension Allen Loyd V Jr	Mar/Apr 2021 Pg. 144
Compounding in the Pharmacy Curriculum: Beyond the Basics Hinkle Amanda R, Newton Gail D	May/Jun 2004 Pg. 181-185
Estradiol 0.5-mg, 1-mg, or 2-mg Capsules Allen Loyd V Jr	May/Jun 2013 Pg. 230
Basics of Compounding: Special Capsules Allen Loyd V Jr	May/Jun 2016 Pg. 209-214
Mupirocin Calcium 2% Cream Allen Loyd V Jr	Jan/Feb 2016 Pg. 52
Resveratrol, Tocopherol Acetate, and Niacinamide Topical Gel-Cream Allen Loyd V Jr	Jan/Feb 2016 Pg. 53
Sodium Acetate 2-mEq/mL and 4-mEq/mL Injections Allen Loyd V Jr	Jan/Feb 2012 Pg. 75
Calcium Chloride 10% Injection Allen Loyd V Jr	Jan/Feb 2012 Pg. 70
Return to Top